CASI Pharmaceuticals
CASI
#9764
Rank
HK$0.23 B
Marketcap
HK$14.98
Share price
2.66%
Change (1 day)
-18.27%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2022 (TTM): -HK$23.32

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$23.13. In 2021 the company made an earnings per share (EPS) of -HK$21.11 an increase over its 2020 EPS that were of -HK$33.92.

EPS history for CASI Pharmaceuticals from 1996 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$23.3210.49%
2021-HK$21.11-37.76%
2020-HK$33.92-8.96%
2019-HK$37.2550%
2018-HK$24.8477.78%
2017-HK$13.97-7.42%
2016-HK$15.09-11.63%
2015-HK$17.07-75.56%
2014-HK$69.85309.09%
2013-HK$17.07-72.84%
2012-HK$62.8768.75%
2011-HK$37.25-48.94%
2010-HK$72.96-19.66%
2009-HK$90.81-62.01%
2008-HK$239.05-0%
2007-HK$239.05-62.67%
2006-HK$640.30134.38%
2005-HK$273.19-13.51%
2004-HK$315.88-44.78%
2003-HK$572.00-62.36%
2002-HK$1,520-26.14%
2001-HK$2,057-20.72%
2000-HK$2,59513.43%
1999-HK$2,288150.47%
1998-HK$913.4994.55%
1997-HK$469.5527.91%
1996-HK$367.11